Por favor, use este identificador para citar o enlazar este Item:http://hdl.handle.net/20.500.12105/14406
Título
Metabolomic changes after DAAs therapy are related to the improvement of cirrhosis and inflammation in HIV/HCV-coinfected patients
Autor(es)
Virseda-Berdices, Ana ISCIII | Rojo, David | Martinez, Isidoro ISCIII | Berenguer, Juan | González-García, Juan | Brochado-Kith, Oscar ISCIII | Fernandez-Rodriguez, Amanda ISCIII | Díez, Cristina | Hontañon, Víctor | Pérez-Latorre, Leire | Micán, Rafael | Barbas, Coral | Resino, Salvador ISCIII | Jimenez-Sousa, Maria Angeles ISCIII | ESCORIAL Study Group
Fecha de publicación
2022-03
Cita
Biomed Pharmacother. 2022 Mar;147:112623.
Idioma
Inglés
Tipo de documento
journal article
Resumen
Background: A better understanding of the evolution of cirrhosis after hepatitis C virus (HCV) clearance is essential since the reversal of liver injury may not happen. We aimed to assess the evolution of plasma metabolites after direct-acting antivirals (DAAs) therapy and their association with liver disease scores in HIV/HCV-coinfected patients with advanced HCV-related cirrhosis. Methods: We performed a prospective study in 49 cirrhotic patients who started DAAs therapy. Data and samples were collected at baseline and 36 weeks after SVR. Metabolomics analysis was carried out using gas chromatography-mass spectrometry and liquid chromatography-mass spectrometry. Inflammation-related biomarkers were analyzed using ProcartaPlex Immunoassays. Results: At 36 weeks after SVR, patients experienced significant decrease in taurocholic acid, 2,3-butanediol, and LPC(18:0); while several phosphatidylcholines (LPC(16:1), LPC(18:1), LPC(20:4), and PC(16:0/9:0(CHO))/PC(16:0/9:0(COH)), 2-keto-n-caproic acid/2-keto-isocaproic acid and N-methyl alanine increased, compared to baseline. The plasma decrease in taurocholic acid was associated with a reduction in Child-Turcotte-Pugh (CTP) (AMR=3.39; q-value=0.006) and liver stiffness measurement (LSM) (AMR=1.06; q-value<0.001), the plasma increase in LPC(20:4) was related to a reduction in LSM (AMR=0.98; q-value=0.027), and the rise of plasma 2-keto-n-caproic acid/2-keto-isocaproic acid was associated with a reduction in CTP (AMR=0.35; q-value=0.004). Finally, plasma changes in taurocholic acid were directly associated with inflammation-related biomarkers, while changes in LPC(20:4) were inversely associated. Conclusions: Plasma metabolomic profile changed after HCV clearance with all oral-DAAs in HIV/HCV-coinfected with advanced HCV-related cirrhosis. Changes in plasma levels of LPC (20: 4), 2-keto-n-caproic acid/2-keto-isocaproic acid, and taurocholic acid were related to improvements in cirrhosis scores and inflammatory status of patients.
Palabras clave
Versión en línea
DOI
Aparece en las colecciones
Ficheros en el ítem
- Nombre:
- MetabolomicChangesAfterDAAs_20 ...
- Tamaño:
- 2.120Mb
- Formato:
- Descripción:
- Artículo principal
- Nombre:
- MetabolomicChangesAfterDAAsSup ...
- Tamaño:
- 160.8Kb
- Formato:
- Microsoft Word 2007